Published in CA Cancer J Clin on March 05, 2008
Virtual Colonoscopy Using Omnipaque as a Contrast Agent | NCT04582500
Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med (2009) 10.01
Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72
Complications following colonoscopy with anesthesia assistance: a population-based analysis. JAMA Intern Med (2013) 4.07
Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA (2008) 3.53
Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology (2008) 3.11
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med (2008) 2.74
The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc (2011) 2.73
Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol (2009) 2.60
Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol (2008) 2.56
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology (2008) 2.56
Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut (2013) 2.50
Health disparities among lesbian, gay, and bisexual older adults: results from a population-based study. Am J Public Health (2013) 2.46
Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol (2012) 2.40
Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39
A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology (2015) 2.14
The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila) (2014) 2.08
Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers. Genet Med (2010) 2.07
Socioeconomic and other predictors of colonoscopy preparation quality. Dig Dis Sci (2010) 2.04
Screening colonoscopy for colorectal cancer in asymptomatic people: a meta-analysis. Dig Dis Sci (2008) 2.03
Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer (2011) 2.01
Individualizing colonoscopy screening by sex and race. Gastrointest Endosc (2009) 1.96
In defense of body CT. AJR Am J Roentgenol (2009) 1.96
Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med (2009) 1.94
Prevalence and correlates of skin cancer screening among middle-aged and older white adults in the United States. Am J Med (2010) 1.90
Recommendations for post-polypectomy surveillance in community practice. Dig Dis Sci (2011) 1.89
Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history. Lancet Oncol (2013) 1.83
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res (2009) 1.80
Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. J Natl Cancer Inst (2015) 1.77
A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making (2011) 1.77
Spectroscopic microvascular blood detection from the endoscopically normal colonic mucosa: biomarker for neoplasia risk. Gastroenterology (2008) 1.73
Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract. CMAJ (2011) 1.69
The cost-effectiveness of screening for colorectal cancer. CMAJ (2010) 1.67
Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol (2012) 1.65
Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol (2009) 1.64
Comparing 3 values clarification methods for colorectal cancer screening decision-making: a randomized trial in the US and Australia. J Gen Intern Med (2013) 1.57
Behind closed doors: physician-patient discussions about colorectal cancer screening. J Gen Intern Med (2009) 1.55
Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia. Am J Med (2012) 1.54
Principles of cancer screening: lessons from history and study design issues. Semin Oncol (2010) 1.52
The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial. Med Decis Making (2010) 1.51
Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database. BMJ (2015) 1.51
Effectiveness of a web-based colorectal cancer screening patient decision aid: a randomized controlled trial in a mixed-literacy population. Am J Prev Med (2011) 1.51
Offering annual fecal occult blood tests at annual flu shot clinics increases colorectal cancer screening rates. Ann Fam Med (2009) 1.51
Detection of colorectal neoplasia by colonoscopy in average-risk patients age 40-49 versus 50-59 years. Dig Dis Sci (2011) 1.49
Whites and blacks have similar risk of metachronous advanced colorectal neoplasia. Dig Dis Sci (2014) 1.49
The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res (Phila) (2012) 1.48
Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol (2009) 1.46
A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same. Ann Behav Med (2011) 1.46
Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol (2014) 1.44
Prevalence of any size adenomas and advanced adenomas in 40- to 49-year-old individuals undergoing screening colonoscopy because of a family history of colorectal carcinoma in a first-degree relative. Gastrointest Endosc (2011) 1.42
Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med (2009) 1.41
Effect of language on colorectal cancer screening among Latinos and non-Latinos. Cancer Epidemiol Biomarkers Prev (2008) 1.39
Short duration of sleep increases risk of colorectal adenoma. Cancer (2010) 1.39
An overview of colorectal cancer survival rates and prognosis in Asia. World J Gastrointest Oncol (2012) 1.37
Estimation of newborn risk for child or adolescent obesity: lessons from longitudinal birth cohorts. PLoS One (2012) 1.35
Physicians' colorectal cancer screening discussion and recommendation patterns. Cancer Epidemiol Biomarkers Prev (2011) 1.35
Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol (2014) 1.35
Effect of computer-aided detection for CT colonography in a multireader, multicase trial. Radiology (2010) 1.29
Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev (2016) 1.29
Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med (2010) 1.27
Incidence and mortality rates for colorectal cancer in Puerto Rico and among Hispanics, non-Hispanic whites, and non-Hispanic blacks in the United States, 1998-2002. Cancer (2009) 1.26
A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings. Ann Behav Med (2009) 1.26
Informed decision making changes test preferences for colorectal cancer screening in a diverse population. Ann Fam Med (2010) 1.26
Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc (2012) 1.25
Normalized distance along the colon centerline: a method for correlating polyp location on CT colonography and optical colonoscopy. AJR Am J Roentgenol (2009) 1.24
Construct validity and invariance of four factors associated with colorectal cancer screening across gender, race, and prior screening. Cancer Epidemiol Biomarkers Prev (2008) 1.23
Electronic patient messages to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med (2010) 1.21
Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials (2014) 1.19
EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis. World J Gastroenterol (2010) 1.19
Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev (2010) 1.19
The second ESGAR consensus statement on CT colonography. Eur Radiol (2012) 1.16
Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challenges. J Cancer (2014) 1.16
Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma. Br J Cancer (2014) 1.13
Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Ann Intern Med (2010) 1.13
Promoting colorectal cancer screening discussion: a randomized controlled trial. Am J Prev Med (2013) 1.13
Interventions to promote colorectal cancer screening: an integrative review. Nurs Outlook (2012) 1.12
Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior. Ann Behav Med (2010) 1.12
Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia. J Gastrointest Surg (2008) 1.12
Patient satisfaction with colonoscopy: a literature review and pilot study. Can J Gastroenterol (2009) 1.11
Narratives that address affective forecasting errors reduce perceived barriers to colorectal cancer screening. Soc Sci Med (2010) 1.10
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10
Preferences for colorectal cancer screening strategies: a discrete choice experiment. Br J Cancer (2010) 1.10
Patients' preferences and priorities regarding colorectal cancer screening. Med Decis Making (2012) 1.09
Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci (2015) 1.09
Culturally targeted patient navigation for increasing african americans' adherence to screening colonoscopy: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2013) 1.09
Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial. Am J Prev Med (2012) 1.08
Healthy colon, healthy life (colon sano, vida sana): colorectal cancer screening among Latinos in Santa Clara, California. J Cancer Educ (2010) 1.08
Development and validation of a primary care-based family health history and decision support program (MeTree). N C Med J (2013) 1.07
Factors influencing colorectal cancer screening participation. Gastroenterol Res Pract (2011) 1.07
Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis. AJR Am J Roentgenol (2011) 1.07
What is lacking in current decision aids on cancer screening? CA Cancer J Clin (2013) 1.06
Validity of self-reported colorectal cancer test use in different racial/ethnic groups. Fam Pract (2011) 1.06
Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review. Can J Gastroenterol Hepatol (2014) 1.06
Colorectal cancer video for the deaf community: a randomized control trial. J Cancer Educ (2010) 1.06
Computer-delivered tailored intervention improves colon cancer screening knowledge and health beliefs of African-Americans. Health Educ Res (2012) 1.06
Developing model-based algorithms to identify screening colonoscopies using administrative health databases. BMC Med Inform Decis Mak (2013) 1.06
Change to FIT increased CRC screening rates: evaluation of a US screening outreach program. Am J Manag Care (2012) 1.05
Influence of primary care use on population delivery of colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (2009) 1.05
Unwillingness to participate in colorectal cancer screening: examining fears, attitudes, and medical mistrust in an ethnically diverse sample of adults 50 years and older. Am J Health Promot (2012) 1.04
Retrograde-viewing device improves adenoma detection rate in colonoscopies for surveillance and diagnostic workup. World J Gastroenterol (2012) 1.04
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med (2012) 16.55
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med (2014) 11.07
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51
Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science (2003) 6.85
Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2002) 6.63
Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 6.54
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin (2010) 6.45
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology (2005) 6.34
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res (2005) 5.68
American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin (2002) 5.56
Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet (2003) 5.40
A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos). Gastrointest Endosc (2009) 5.38
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology (2011) 5.17
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2010) 4.76
Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen (2010) 4.72
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin (2006) 4.69
Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol (2007) 4.62
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med (2005) 4.38
Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA (2006) 4.34
Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol (2006) 4.22
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc (2007) 4.09
Complications following colonoscopy with anesthesia assistance: a population-based analysis. JAMA Intern Med (2013) 4.07
Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol (2009) 3.96
Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology (2007) 3.94
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res (2006) 3.81
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst (2007) 3.80
Prophylactic clip closure reduced the risk of delayed postpolypectomy hemorrhage: experience in 277 clipped large sessile or flat colorectal lesions and 247 control lesions. Gastrointest Endosc (2013) 3.72
Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin (2006) 3.67
Supplemental oxygen impairs detection of hypoventilation by pulse oximetry. Chest (2004) 3.55
Small changes in expression affect predisposition to tumorigenesis. Nat Genet (2001) 3.37
Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology (2002) 3.28
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc (2002) 3.16
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol (2004) 3.10
A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med (2005) 3.01
Incidence and predictors of "late" recurrences after endoscopic piecemeal resection of large sessile adenomas. Gastrointest Endosc (2009) 2.99
Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation (2004) 2.91
The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer (2002) 2.85
The efficacy and safety of pain management before and after implementation of hospital-wide pain management standards: is patient safety compromised by treatment based solely on numerical pain ratings? Anesth Analg (2005) 2.83
Maximizing control of tip deflection with sound ergonomics: the "left hand shaft grip". Gastrointest Endosc (2007) 2.82
Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc (2007) 2.82
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin (2007) 2.81
Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2011) 2.76
Counterpoint: Overdiagnosis in breast cancer screening. J Am Coll Radiol (2014) 2.75
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med (2008) 2.74
One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines. Ann Intern Med (2012) 2.70
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology (2008) 2.56
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2011) 2.51
Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut (2013) 2.50
Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila) (2008) 2.47
High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening. Am J Gastroenterol (2010) 2.47
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol (2012) 2.45
Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer (2008) 2.41
Efficacy of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy: a randomized controlled trial. Am J Gastroenterol (2006) 2.39
Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J (2014) 2.37
Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer (2007) 2.36